Search research articles
Contact Us
Filters
Showing results (81-90 of 166) with videos related to
Page
of 17
Sort By:
The International Journal of Artificial Organs
|
December 1, 1993
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients
M Di Nicola, S Siena, M Bregni, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 22, 2017
Lipid-lowering therapy of everolimus-related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET)
V De Gennaro Colonna, C Pavanello, F Rusconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2006
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer
A Sartore-Bianchi, G Cerea, I Schiavetto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1993
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy
A M Gianni, S Siena, M Bregni, et al.
Experimental Hematology
|
December 1, 1995
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
S Siena, M Di Nicola, M Bregni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1989
In vivo effects in mice of an anti-T cell immunotoxin
F Marcucci, D A Lappi, M Ghislieri, et al.
Blood Cells, Molecules & Diseases
|
January 1, 1996
Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential
E F Srour, M Bregni, C M Traycoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1989
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis
M Bregni, S Siena, A Neri, et al.
Blood
|
February 15, 1989
B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells
M Bregni, S Siena, A Formosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
A M Gianni, M Bregni, S Siena, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 166) with videos related to
Sort By:
Page
of 17
The International Journal of Artificial Organs
|
December 1, 1993
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients
M Di Nicola, S Siena, M Bregni, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 22, 2017
Lipid-lowering therapy of everolimus-related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET)
V De Gennaro Colonna, C Pavanello, F Rusconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2006
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer
A Sartore-Bianchi, G Cerea, I Schiavetto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1993
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy
A M Gianni, S Siena, M Bregni, et al.
Experimental Hematology
|
December 1, 1995
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
S Siena, M Di Nicola, M Bregni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1989
In vivo effects in mice of an anti-T cell immunotoxin
F Marcucci, D A Lappi, M Ghislieri, et al.
Blood Cells, Molecules & Diseases
|
January 1, 1996
Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential
E F Srour, M Bregni, C M Traycoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1989
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis
M Bregni, S Siena, A Neri, et al.
Blood
|
February 15, 1989
B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells
M Bregni, S Siena, A Formosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
A M Gianni, M Bregni, S Siena, et al.
Page
of 17